|
 PH&T is an Italian pharmaceutical company engaged in research, development and production of generic drugs for specialist therapies and innovative medical devices, sold worldwide through licensees and distributors.
The company was founded in Milan in 1991 with the aim of selecting and developing niche products and selling them through firm commercial partnerships. In 2011 we are celebrating 20 years of activity.
PH&T specializes in difficult to formulate prescription products and has a consolidated experience in oral slow release, eye drop, nasal spray and injectable forms. Our offer allows generic companies to complement their product portfolio with difficult-to-formulate, not top-selling pharmaceuticals.
|
|
 Epoprostenol PH&T Sterile freeze-dried powder 0,5mg and 1,5mg + solvent has been successfully launched in Italy and Netherlands.
October 2011 The launch of Epoprostenol PH&T has been successfully accomplished by Ibisqus in Italy and Devrimed in Netherlands.
|
|
Read more...
|
Exemestane PH&T 25 mg. sugar coated tablets, has successfully finalised the European Decentralised Procedure to receive Marketing Authorisation in Germany, Greece, Netherlands, Italy, Spain and United Kingdom.
August 2011 Exemestane PH&T, a third-generation aromatase inhibitor, is an antineoplastic agent.
|
|
Read more...
|
|
PH&T at CPhI 2011 - 51E37
PH&T will be present as an exhibitor 25 - 27 October in Messe Frankfurt, Germany for CPhI Worldwide 2011, the world's leading pharmaceutical networking event with 28,500 attendees from 140 countries.
STAND Number: 51E37
|
|
Read more...
|
Latanoprost PH&T (Latacris), 0,005% eye drops, 2,5 ml. solution, has successfully finalised the European Decentralised Procedure to receive Marketing Authorisation in Germany, Greece, Ireland, Poland and United Kingdom.
April 2011 Latanoprost PH&T is indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension..
|
|
Read more...
|
|
|
